BIOMAT Database Logo BIOMAT Database Logo

[Clinical and hemodynamic effects of captopril in patients with arterial hypertension and obliterative arteriopathy of the legs]. 1986

G Bolognini, and G Iezzi Biase

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001162 Arteriosclerosis Obliterans Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION. Obliterans, Arteriosclerosis

Related Publications

G Bolognini, and G Iezzi Biase
[Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
January 1987, Angiologia,
G Bolognini, and G Iezzi Biase
[Arterial pressure in the toes of patients with obliterative arteriopathy of the legs].
January 1984, Annali italiani di chirurgia,
G Bolognini, and G Iezzi Biase
[Atherogenic risk factors in patients with obliterative arteriopathy of the legs].
December 1999, Minerva cardioangiologica,
G Bolognini, and G Iezzi Biase
[Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension].
January 1981, Minerva nefrologica,
G Bolognini, and G Iezzi Biase
[Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs].
December 1999, Minerva cardioangiologica,
G Bolognini, and G Iezzi Biase
[Doppler ultrasonography in chronic obliterative arteriopathy of the legs].
February 1984, Chirurgia italiana,
G Bolognini, and G Iezzi Biase
[Incidence of mesenteric ischemia in patients with obliterative arteriopathy of the legs. Angiographic study].
January 1986, Minerva cardioangiologica,
G Bolognini, and G Iezzi Biase
[Value of functional vascular study during endoluminal angioplasty in patients with obliterative arteriopathy of the legs].
January 1984, Annales de cardiologie et d'angeiologie,
G Bolognini, and G Iezzi Biase
Persistent hemodynamic and clinical improvement after captopril in patients with pulmonary hypertension.
August 1986, Herz,
G Bolognini, and G Iezzi Biase
Arterial collateral vessels in legs with obliterative arteriosclerosis.
June 1978, Scandinavian journal of clinical and laboratory investigation,
Copied contents to your clipboard!